ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1783

Nerve Growth Factor Causes Sensitization, Nociceptor Sprouting, Synovitis, And Osteophyte Formation In Naïve Murine Joints

alia obeidat1, michael Newton2, Jun Li1, Baofeng Hu3, Shingo Ishihara4, Lindsey Lammlin2, Lucas Junginger2, Easton Farrell2, Frank Ko1, Richard Miller5, Carla Scanzello6, Tristan Maerz7, Rachel Miller8 and Anne-Marie Malfait9, 1Rush University Medical Center, Chicago, 2University Of Michigan, Ann Arbor, 3University of Pennsylvania, Wynnewood, PA, 4Rush University, Chicago, 5Northwestern University, Chicago, 6University of Pennsylvania, Philadelphia, 7University of Michigan, Ann Arbor, MI, 8Rush University Medical Center, Chicago, IL, 9rush university, CHICAGO, IL

Meeting: ACR Convergence 2025

Keywords: Animal Model, Osteoarthritis, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The neurotrophin, nerve growth factor (NGF), a key mediator of pain and inflammation, is increased in joints with osteoarthritis (OA). Neutralizing NGF with monoclonal antibodies has shown promising analgesic effects in painful knee OA, but clinical development was stopped owing to ill-understood side effects in the joints1. Knowledge about the biological effects of long-term exposure of healthy joint tissues to NGF is limited. Therefore, we aimed to explore the effects of repeated intra-articular (IA) injections of NGF into the knee joints of healthy mice on sensitization and pain, as well as joint innervation and structure.

Methods: All animal experiments were IACUC approved. Five experiments were conducted, all using 12-week old naïve male mice. In Experiment 1, NGF (50 ng or 500 ng in 5 uL, n=5 mice/group) or vehicle control (0.1% BSA in PBS, n=5 mice) was injected IA into the right knee joint of wildtype (WT) C57BL/6 mice, twice a week for 4 weeks. We assessed knee swelling and knee hyperalgesia as described2, as well as joint histopathology. Synovial changes including hyperplasia, cellularity and fibrosis were assessed by four different scorers blinded to treatment groups3. In Experiment 2, mice were injected with NGF (500ng) or vehicle, twice a week for 4 weeks and microCT of the knee was performed. In Experiment 3, NaV1.8-tdTomato reporter mice were injected with NGF (500ng) or vehicle, twice a week for 4 weeks, and joint innervation was assessed4. In Experiment 4, WT mice received 500ng NGF or vehicle twice a week for 4 weeks and were used for single cell RNA sequencing (scRNAseq) of the synovium. In Experiment 5, L3-L5 DRGs were collected from mice that received 3 IA injections of 500ng NGF or vehicle twice a week for 10 days and processed for bulk RNA sequencing.

Results: Repeated bi-weekly IA injections of both doses of NGF caused knee hyperalgesia in naïve mice (Fig. 1A). NGF caused dose-dependent knee swelling (Fig. 1B), synovial pathology (Fig. 1C), increased bone mineral density and trabecular bone thickness in the medial subchondral bone. NGF also caused osteophyte growth in the medial compartment, but no cartilage degeneration (Fig. 1D). NGF injection caused sprouting of NaV1.8+ neurons in the medial but not the lateral synovium (Fig. 1E). ScRNAseq of the synovium revealed upregulated genes related to neuronal sprouting, synovial fibrosis and ossification, confirming histopathological findings (Fig. 2). Bulk RNA seq of DRG showed upregulated pathways related to axonal growth (Fig. 3).

Conclusion: In healthy mouse knees, NGF induced mechanical sensitization, synovitis, neoinnervation in the medial synovium, and subchondral bone changes and osteophyte growth in the medial compartment, thus capturing many pathological changes observed in OA, except cartilage damage. It will be critical to describe in great depth the distribution of NGF and its receptors in all joint tissues, and how they change with age and disease. Such insights are especially important, as they may enable the modulation of NGF signaling to selectively target pain pathways while maintaining its protective functions. Hochberg, OAC, 2015. Miller, JCI Insight, 2018.Obeidat, OAC, 2024.Obeidat, OAC, 2019.

Supporting image 1Figure 1: (A) Knee hyperalgesia was assessed for mice given repeated intra-articular injections of recombinant murine NGF (i.a. 50 ng or 500 ng, 5 µL, 2x/week) or vehicle (5 µL, 2x/week) for 4 weeks at 0-, 2, and 4-week (B) Knee swelling was assessed in wild-type mice given NGF (50 ng or 500 ng) or vehicle. Red arrowhead indicates the first injection. (C) Synovial cellularity, fibrosis and hyperplasia were evaluated in wild-type mice that received NGF at 50 ng or 500 ng or vehicle. (D) Osteophyte width measured in µm and cartilage degeneration scores. (E) Quantification of neuronal signal in the medial and lateral synovium of NaV1.8-tdTomato mice injected with vehicle or NGF. (A) Two-way ANOVA with Dunnett’s post-test. (C-D) Two-way ANOVA with Sidak’s post-test. (E) Unpaired two-tailed t test.

Supporting image 2Figure 2: NGF-induced changed in lining fibroblast transcriptome. (A) Heatmap of top gene set enrichment analysis-derived leading-edge genes, demonstrating coordinated upregulation of genes related to collagen fibril organization, smoothened signaling, and ossification. (B) Transcription factor binding motif analysis (RcisTarget) of lining fibroblasts in NGF v. Veh revealed significantly enriched motif transfac_pre_M01014 for the Sox family of transcription factors, predicted by direct annotation. (C) Expression of predicted transcription factors by lining fibroblasts in Veh and NGF groups, demonstrating highest expression of Sox5 (red arrow). (D) Gene regulatory network plot for Sox5 in lining fibroblasts.

Supporting image 3Figure 3: Differential gene expression analysis on bulk RNAseq conducted on DRGs collected after 3 injections of NGF or vehicle. (A) Volcano plot showing all genes that were not filtered out by DESeq2 (15,664). Red indicates genes that met the Padj cut-off < 0.05. No fold change cutoff was applied. Genes of interest are labeled. (B) Top 50 genes by padj, ordered by log2 fold change with the size of the bubble mapped to the adjusted p-value. String network showing known relationships to Ngf and to Ntrk1 (highlighted in yellow). (C) Functional enrichment was performed on the upregulated DEG list using Cytoscape String Enrichment; Interacting genes contributing to the top 5 Reactome pathways are shown using a redundancy cutoff of 0.5. Hub genes are highlighted in yellow.


Disclosures: a. obeidat: None; m. Newton: None; J. Li: None; B. Hu: None; S. Ishihara: None; L. Lammlin: None; L. Junginger: None; E. Farrell: None; F. Ko: None; R. Miller: None; C. Scanzello: None; T. Maerz: None; R. Miller: None; A. Malfait: None.

To cite this abstract in AMA style:

obeidat a, Newton m, Li J, Hu B, Ishihara S, Lammlin L, Junginger L, Farrell E, Ko F, Miller R, Scanzello C, Maerz T, Miller R, Malfait A. Nerve Growth Factor Causes Sensitization, Nociceptor Sprouting, Synovitis, And Osteophyte Formation In Naïve Murine Joints [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/nerve-growth-factor-causes-sensitization-nociceptor-sprouting-synovitis-and-osteophyte-formation-in-naive-murine-joints/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nerve-growth-factor-causes-sensitization-nociceptor-sprouting-synovitis-and-osteophyte-formation-in-naive-murine-joints/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology